ARCHIVES

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

This article is from The Cancer Letter archive.

Vol. 13 No. 46 | November 27, 1987

Download PDF Visit The Full Archive

Related Articles

Blue Cross, Broder Skirmish On Coverage Of Group C Drugs

November 3, 1989

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

June 14, 2013

ASCO To Open Abstracts To Everyone Prior To Annual Meeting.

November 16, 2007

Program Announcement On Effects Of Low Dose Radiation

October 2, 1981

In Brief: McIntyre New AACI President, Salmon President Elect; Hubbard NCI AD; Underleider CIB Chief

September 30, 1988

Conversation with The Cancer Letter: IU’s Loehrer Discusses “Business Decision” To Close Bloomington Proton Beam Center

October 17, 2014